EdgarLookup

SELECTIVE INSURANCE GROUP INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SELECTIVE INSURANCE GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
8.7%
Profit Margin
Net income ÷ revenue
3.1%
Return on Assets
Net income ÷ assets
3.2x
Debt-to-Equity
Total liabilities ÷ equity
+9.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.34B Feb 9, 2026
FY2025 Dec 31, 2024 $4.86B Feb 9, 2026
FY2025 Dec 31, 2023 $4.23B Feb 9, 2026
FY2024 Dec 31, 2022 $3.56B Feb 10, 2025
FY2023 Dec 31, 2021 $3.38B Feb 9, 2024
FY2020 Dec 31, 2020 $798.43M Feb 12, 2021
FY2020 Sep 30, 2020 $776.57M Feb 12, 2021
FY2020 Jun 30, 2020 $682.45M Feb 12, 2021
FY2020 Mar 31, 2020 $664.83M Feb 12, 2021
FY2020 Dec 31, 2019 $728.90M Feb 12, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $466.41M Feb 9, 2026
FY2025 Dec 31, 2024 $207.01M Feb 9, 2026
FY2025 Dec 31, 2023 $365.24M Feb 9, 2026
FY2024 Dec 31, 2022 $224.89M Feb 10, 2025
FY2023 Dec 31, 2021 $403.84M Feb 9, 2024
FY2020 Dec 31, 2020 $127.06M Feb 12, 2021
FY2020 Sep 30, 2020 $69.88M Feb 12, 2021
FY2020 Jun 30, 2020 $34.18M Feb 12, 2021
FY2020 Mar 31, 2020 $15.24M Feb 12, 2021
FY2020 Dec 31, 2019 $81.86M Feb 12, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.23B Feb 9, 2026
FY2025 Dec 31, 2024 $1.10B Feb 9, 2026
FY2025 Dec 31, 2023 $758.91M Feb 9, 2026
FY2024 Dec 31, 2022 $802.41M Feb 10, 2025
FY2023 Dec 31, 2021 $771.42M Feb 9, 2024
FY2022 Dec 31, 2020 $554.05M Feb 10, 2023
FY2021 Dec 31, 2019 $477.50M Feb 11, 2022
FY2020 Dec 31, 2018 $454.94M Feb 12, 2021
FY2019 Dec 31, 2017 $379.55M Feb 12, 2020
FY2012 Dec 31, 2012 $226.70M Feb 21, 2013

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $38.74M Feb 9, 2026
FY2025 Dec 31, 2024 $30.81M Feb 9, 2026
FY2025 Dec 31, 2023 $22.63M Feb 9, 2026
FY2024 Dec 31, 2022 $26.02M Feb 10, 2025
FY2023 Dec 31, 2021 $22.16M Feb 9, 2024
FY2022 Dec 31, 2020 $22.06M Feb 10, 2023
FY2021 Dec 31, 2019 $30.99M Feb 11, 2022
FY2020 Dec 31, 2018 $16.11M Feb 12, 2021
FY2010 Dec 31, 2010 $6.52M Feb 25, 2011
FY2010 Dec 31, 2009 $8.21M Feb 25, 2011

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.16B Feb 9, 2026
FY2025 Dec 31, 2024 $13.51B Feb 9, 2026
FY2024 Dec 31, 2023 $11.80B Feb 10, 2025
FY2023 Dec 31, 2022 $10.80B Feb 9, 2024
FY2022 Dec 31, 2021 $10.46B Feb 10, 2023
FY2021 Dec 31, 2020 $9.69B Feb 11, 2022
FY2020 Dec 31, 2019 $8.80B Feb 12, 2021
FY2019 Dec 31, 2018 $7.95B Feb 12, 2020
FY2018 Dec 31, 2017 $7.69B Feb 15, 2019
FY2017 Dec 31, 2016 $7.36B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.55B Feb 9, 2026
FY2025 Dec 31, 2024 $10.39B Feb 9, 2026
FY2024 Dec 31, 2023 $8.85B Feb 10, 2025
FY2023 Dec 31, 2022 $8.27B Feb 9, 2024
FY2022 Dec 31, 2021 $7.48B Feb 10, 2023
FY2021 Dec 31, 2020 $6.95B Feb 11, 2022
FY2020 Dec 31, 2019 $6.60B Feb 12, 2021
FY2019 Dec 31, 2018 $6.16B Feb 12, 2020
FY2018 Dec 31, 2017 $5.97B Feb 15, 2019
FY2017 Dec 31, 2016 $5.82B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.61B Feb 9, 2026
FY2025 Dec 31, 2024 $3.12B Feb 9, 2026
FY2025 Dec 31, 2023 $2.95B Feb 9, 2026
FY2024 Dec 31, 2022 $2.53B Feb 10, 2025
FY2023 Dec 31, 2021 $2.98B Feb 9, 2024
FY2022 Dec 31, 2020 $2.74B Feb 10, 2023
FY2021 Dec 31, 2019 $2.19B Feb 11, 2022
FY2020 Dec 31, 2018 $1.79B Feb 12, 2021
FY2019 Dec 31, 2017 $1.71B Feb 12, 2020
FY2018 Dec 31, 2016 $1.53B Feb 15, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.85M Feb 9, 2026
FY2025 Dec 31, 2024 $7.85M Feb 9, 2026
FY2024 Dec 31, 2023 $7.85M Feb 10, 2025
FY2023 Dec 31, 2022 $7.85M Feb 9, 2024
FY2022 Dec 31, 2021 $7.85M Feb 10, 2023
FY2021 Dec 31, 2020 $7.85M Feb 11, 2022
FY2020 Dec 31, 2019 $7.85M Feb 12, 2021
FY2019 Dec 31, 2018 $7.85M Feb 12, 2020
FY2018 Dec 31, 2017 $7.85M Feb 15, 2019
FY2017 Dec 31, 2016 $7.85M Feb 23, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.50B Feb 9, 2026
FY2025 Dec 31, 2024 $3.14B Feb 9, 2026
FY2024 Dec 31, 2023 $3.03B Feb 10, 2025
FY2023 Dec 31, 2022 $2.75B Feb 9, 2024
FY2022 Dec 31, 2021 $2.60B Feb 10, 2023
FY2021 Dec 31, 2020 $2.27B Feb 11, 2022
FY2020 Dec 31, 2019 $2.08B Feb 12, 2021
FY2019 Dec 31, 2018 $1.86B Feb 12, 2020
FY2018 Dec 31, 2017 $1.70B Feb 15, 2019
FY2017 Dec 31, 2016 $1.57B Feb 23, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $507.94M Feb 10, 2025
FY2024 Dec 31, 2023 $503.95M Feb 10, 2025
FY2023 Dec 31, 2022 $504.68M Feb 9, 2024
FY2022 Dec 31, 2021 $506.05M Feb 10, 2023
FY2021 Dec 31, 2020 $550.74M Feb 11, 2022
FY2020 Dec 31, 2019 $550.60M Feb 12, 2021
FY2019 Dec 31, 2018 $439.54M Feb 12, 2020
FY2018 Dec 31, 2017 $439.12M Feb 15, 2019
FY2017 Dec 31, 2016 $438.67M Feb 23, 2018
FY2016 Dec 31, 2015 $328.19M Feb 22, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 9, 2026
FY2025 Dec 31, 2024 3 Feb 9, 2026
FY2025 Dec 31, 2023 5 Feb 9, 2026
FY2024 Dec 31, 2022 3 Feb 10, 2025
FY2023 Dec 31, 2021 6 Feb 9, 2024
FY2020 Dec 31, 2020 2 Feb 12, 2021
FY2020 Sep 30, 2020 1 Feb 12, 2021
FY2020 Jun 30, 2020 0 Feb 12, 2021
FY2020 Mar 31, 2020 0 Feb 12, 2021
FY2020 Dec 31, 2019 1 Feb 12, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 7 Feb 9, 2026
FY2025 Dec 31, 2024 3 Feb 9, 2026
FY2025 Dec 31, 2023 5 Feb 9, 2026
FY2024 Dec 31, 2022 3 Feb 10, 2025
FY2023 Dec 31, 2021 6 Feb 9, 2024
FY2020 Dec 31, 2020 2 Feb 12, 2021
FY2020 Sep 30, 2020 1 Feb 12, 2021
FY2020 Jun 30, 2020 0 Feb 12, 2021
FY2020 Mar 31, 2020 0 Feb 12, 2021
FY2020 Dec 31, 2019 1 Feb 12, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 60.64M Feb 9, 2024
FY2023 Dec 31, 2022 60.34M Feb 9, 2024
FY2023 Dec 31, 2021 60.18M Feb 9, 2024
FY2023 Dec 31, 2020 59.91M Feb 9, 2024
FY2022 Dec 31, 2019 59.46M Feb 10, 2023
FY2021 Dec 31, 2018 58.95M Feb 11, 2022
FY2020 Dec 31, 2017 58.50M Feb 12, 2021
FY2019 Dec 31, 2016 57.97M Feb 12, 2020

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $92.88M Feb 9, 2026
FY2025 Dec 31, 2024 $84.94M Feb 9, 2026
FY2025 Dec 31, 2023 $73.83M Feb 9, 2026
FY2024 Dec 31, 2022 $66.92M Feb 10, 2025
FY2023 Dec 31, 2021 $60.14M Feb 9, 2024
FY2022 Dec 31, 2020 $54.49M Feb 10, 2023
FY2021 Dec 31, 2019 $47.68M Feb 11, 2022
FY2020 Dec 31, 2018 $42.10M Feb 12, 2021
FY2019 Dec 31, 2017 $37.05M Feb 12, 2020
FY2018 Dec 31, 2016 $33.76M Feb 15, 2019